Psychopharmacology

, Volume 91, Issue 1, pp 25–29 | Cite as

The interoceptive discriminative stimuli induced by the novel putative anxiolytic TVX Q 7821: behavioral evidence for the specific involvement of serotonin 5-HT1A receptors

  • David G. SpencerJr
  • Jörg Traber
Original Investigations

Abstract

TVX Q 7821 is active in several behavioral models of anxiety in animals and has a high selective affinity for brain serotonin 5-HT1A receptors in binding assays. In order to determine if interaction with 5-HT1A receptors is important for some of the behavioral effects of this compound, 11 rats were trained to reliably discriminate the interoceptive stimuli induced by TVX Q 7821 (10 mg/kg, IP) from those of saline. Following discrimination acquisition, TVX Q 7821 administration resulted in drug-appropriate responding with an ED50 of 1.5 mg/kg, as did other substances with high affinity for the 5-HT1A receptor: 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT, ED50=0.16 mg/kg), 5-methoxy-N,N-dimethyltryptamine (5-OMe-DMT, ED50=2.5 mg/kg), and buspirone (ED50=5.4 mg/kg). Anxiolytics not acting via the 5-HT1A receptor, like diazepam and pentobarbital, did not induce full TVX Q 7821-appropriate responses. In addition, non-selective 5-HT agonists and antagonists such as bufotenin, quipazine, and methysergide, as well as substances with high affinity for the 5-HT1B receptor (m-trifluoromethylphenylpiperazine, TFMPP; 5-methoxy-3(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole succinate, RU 24969) did not substitute for TVX Q 7821. These data support a selective 5-HT1A mechanism of action in vivo for TVX Q 7821 and indicate the suitability of TVX Q 7821 for the investigation of behavioral correlates of the 5-HT1A receptor.

Key words

Anxiolytic Behavior Drug discrimination 5-HT1A Rats Serotonin TVX Q 7821 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Appel JB, White FJ, Kuhn DM (1978) The use of drugs as discriminative stimuli in behavioral pharmacodynamics. In: Colpaert FC, Rosecrans JA (eds) Stimulus properties of drugs: ten years of progress. Elsevier/North Holland Biomedical, Amsterdam, pp 7–29Google Scholar
  2. Asarch KB, Ransom RW, Shih JC (1985) 5-HT-1a and 5-HT-1b selectivity of two phenylpiperazine derivatives: evidence for 5-HT-1b heterogeneity. Life Sci 36:1265–1273Google Scholar
  3. Cunningham KA, Callahan PM, Appel JB (1985) Similarities in the stimulus effects of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OHDPAT), buspirone, and TVX Q 7821: implications for understanding the actions of novel anxiolytics? Soc Neurosci Abstr 11:45Google Scholar
  4. Dombert WU, Glaser T, Traber J (1985)3H-TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic. Naunyn Schmiedebergs Arch Pharmacol 328:467–470Google Scholar
  5. Glaser T, Dompert WU, Schuurman T, Traber J (1984) 5-HT1 receptors as target for the putative anxiolytic TVX Q 7821. Soc Neurosci Abstr 10:259Google Scholar
  6. Glaser T, Rath M, Traber J, Zilles K, Schleicher A (1985) Autoradiographic identification and topographical analyses of high affinity serotonin receptor subtypes as a target for the novel putative anxiolytic TVX Q 7821. Brain Res 358:129–136Google Scholar
  7. Glaser T, Traber J (1983) Buspirone: action on serotonin receptors in calf hippocampus. Eur J Pharmacol 88:137–138Google Scholar
  8. Glaser T, Traber J (1985) Binding of the putative anxiolytic TVX Q 7821 to hippocampal 5-hydroxytryptamine (5-HT) recognition sites. Naunyn Schmiedebergs Arch Pharmacol 329:211–215Google Scholar
  9. Glennon RA, Young R, Jacyno JM, Slusher M, Rosecrans JA (1983) DOM-stimulus generalization to LSD and other hallucinogenic indole alkylamines. Eur J Pharmacol 86:453–459Google Scholar
  10. Glennon RA, McKenney JD, Young R (1984a) Discriminative stimulus properties of the serotonin agonist (1-(3-trifluoromethylphenyl)piperazine (TFMPP). Life Sci 35:1475–1480Google Scholar
  11. Glennon RA, Titeler M, McKenney JD (1984b) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505–2511Google Scholar
  12. Gozlan H, El Mestikawy S, Pichat L, Glowinsky J, Hamon M (1983) Identification of presynaptic serotonin autoreceptors using a new ligand:3H-PAT. Nature (London) 305:140–142Google Scholar
  13. Gray JA (1982) The neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system. Clarendon, OxfordGoogle Scholar
  14. Hendry JS, Balster RL, Rosecrans JA (1983) Discriminative stimulus properties of buspirone compared to central nervous system depressants in rats. Pharmacol Biochem Behav 19:97–101Google Scholar
  15. Nielsen EB (1985) Discriminative stimulus properties of lysergic acid diethylamide in the monkey. J Pharmacol Exp Ther 234:244–249Google Scholar
  16. Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple3H-5-hydroxytryptamine binding sites in rat brain by neuroleptics. J Neurochem 36:220–226Google Scholar
  17. Peroutka SJ (1985) Selective labelling of 5-HT1a and 5-HT1b binding sites in bovine brain. Brain Res 344:167–171Google Scholar
  18. Peroutka SJ, Snyder SH (1981) Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain. Brain Res 208:339–347Google Scholar
  19. Sills MA, Wolfe BB, Frazer A (1984) Determination of selective and nonselective compounds for the 5-HT1a and 5-HT1b receptor subtypes in rat frontal cortex. J Pharmacol Exp Ther 231:480–487Google Scholar
  20. Spencer DG Jr, Glaser T, Schuurman T, Traber T (1984) Behavioral and neurochemical correlates of the 5-HT1 receptor. Soc Neurosci Abstr 10:1072Google Scholar
  21. Spencer DG Jr, Glaser T, Traber J (1985) The relationship between the interoceptive stimuli produced by 5-methoxy-N,N-dimethyltryptamine and the serotonin 5-HT1 receptor. Naunyn Schmiedebergs Arch Pharmacol 330:R66Google Scholar
  22. Traber J, Davies MA, Dompert WU, Glaser T, Schuurman T, Seidel P-R (1984) Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. Brain Res Bull 12:741–744Google Scholar
  23. Traber J, Glaser T, Spencer DG, Schuurman T, Zilles K, Schleicher A (1985) Behavioral pharmacology and autoradiographic brain distribution of a novel anxiolytic: TVX Q 7821. Proceedings of the IVth World Congress of Biological Psychiatry:80Google Scholar
  24. White FJ, Appel JB (1981) A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine. Psychopharmacology 73:110–115Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • David G. SpencerJr
    • 1
  • Jörg Traber
    • 1
  1. 1.Neurobiology DepartmentTroponwerkeCologne 80Germany

Personalised recommendations